WhichRecall
Class IIReported 2025-08-13

RECOMBINATE, [Antihemophilic Factor (Recombinant)], 5 mL vials, Rx Only, Takeda Pharmaceuticals USA, Cambridge, MA 02142, NDC: 00944-2843-01

Recalled by Cardinal Health Inc.

Reason for Recall

CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.

Advertisement
Recall Number
D-0573-2025
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2025-07-30
Reported
2025-08-13
Distribution
Nationwide Within the U.S.
Code Info
Lot: TRB23802AC, Expires: 03/18/2026; TRA22804AA, Expires: 10/18/2025
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement